×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 8 – Implementing Additional Risk Minimization Tools and Measuring Their Effectiveness
Session Chair(s)
William Gregory, PhD
Senior Director, Safety and Risk Management
Pfizer Inc, United States
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
Strategy
Consultant, United Kingdom
Speaker(s)
Communicating Risks as Part of a Risk Evaluation and Mitigation Strategy
Cynthia LaCivita, PharmD
FDA, United States
Director, Division of Risk Management, OMEPRM, OSE, CDER
Case Study
Michael Richardson, MD, FFPM, FRCP
Bristol-Myers Squibb, United Kingdom
Senior Vice President, WorldWide Patient Safety
Future Direction: CIOMS IX
William Gregory, PhD
Pfizer Inc, United States
Senior Director, Safety and Risk Management
Have an account?